Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Shares Outstanding (Weighted Average): 2022-2023

Historic Shares Outstanding (Weighted Average) for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $26.6 million.

  • Lexeo Therapeutics' Shares Outstanding (Weighted Average) rose 70.06% to $26.6 million in Q4 2023 from the same period last year, while for Sep 2023 it was $15.7 million, marking a year-over-year change of. This contributed to the annual value of $33.1 million for FY2024, which is 24.10% up from last year.
  • Per Lexeo Therapeutics' latest filing, its Shares Outstanding (Weighted Average) stood at $26.6 million for Q4 2023, which was up 70.06% from $15.7 million recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Shares Outstanding (Weighted Average) registered a high of $26.6 million during Q4 2023, and its lowest value of $15.7 million during Q4 2022.
  • In the last 2 years, Lexeo Therapeutics' Shares Outstanding (Weighted Average) had a median value of $15.7 million in 2023 and averaged $17.9 million.
  • Data for Lexeo Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 70.06% (in 2023) over the last 5 years.
  • Over the past 2 years, Lexeo Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $15.7 million in 2022, then soared by 70.06% to $26.6 million in 2023.
  • Its last three reported values are $26.6 million in Q4 2023, $15.7 million for Q3 2023, and $15.7 million during Q2 2023.